Cover Image
市場調查報告書

日本的婦產科用醫療設備市場預測

Japan Gynecological Devices Market Outlook to 2023

出版商 GlobalData 商品編碼 312410
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
日本的婦產科用醫療設備市場預測 Japan Gynecological Devices Market Outlook to 2023
出版日期: 2017年03月06日 內容資訊: 英文 42 Pages
簡介

本報告依市場部門別,提供日本的婦產科用醫療設備銷售額及出貨量的實際成果與今後預測,及平均價格的轉變。再彙整各市場類別的企業佔有率及流通佔有率的資料,主要企業簡介,開發中產品,主要的財務交易情形等相關的最新資訊。

第1章 目錄

第2章 簡介

  • 關於本報告
  • 婦產科用醫療設備市場分類
  • 該報告的市場範圍和定義

第3章 婦產科用醫療設備的日本市場

  • 婦產科用醫療設備的日本市場:收益的實際成果($m)
  • 婦產科用醫療設備的日本市場:收益的預測($m)
    • 女性用絕育手術設備的日本市場:各市場區隔收益的實際成果($m)
    • 子宮內膜燒灼術設備的日本市場:各市場區隔收益的實際成果($m)
    • 子宮肌瘤栓塞手術的日本市場:各市場區隔收益的實際成果($m)
    • 女性用絕育手術設備的日本市場:各市場區隔收益的預測($m)
    • 子宮內膜燒灼術設備的日本市場:各市場區隔收益的預測($m)
    • 子宮肌瘤栓塞手術的日本市場:各市場區隔收益的預測($m)
  • 婦產科用醫療設備的日本市場:出貨量的實際成果
  • 婦產科用醫療設備的日本市場:出貨量的預測
    • 女性用絕育手術設備的日本市場:各市場區隔出貨量的實際成果
    • 子宮內膜燒灼術設備的日本市場:各市場區隔出貨量的實際成果
    • 子宮肌瘤栓塞手術的日本市場:各市場區隔出貨量的實際成果
    • 女性用絕育手術設備的日本市場:各市場區隔出貨量的預測
    • 子宮內膜燒灼術設備的日本市場:各市場區隔出貨量的預測
    • 子宮肌瘤栓塞手術的日本市場:各市場區隔出貨量的預測
  • 婦產科用醫療設備的日本市場:平均銷售價格的轉變
  • 婦產科用醫療設備的日本市場:以收益為準的流通佔有率($m)
  • 婦產科用醫療設備的日本市場:以收益為準的企業佔有率($m)

第4章 日本的婦產科用醫療設備市場主要企業概要

  • Merit Medical Systems, Inc.
  • Johnson & Johnson
  • Hologic, Inc.
  • Conceptus, Inc.
  • CooperSurgical, Inc.
  • Utah Medical Products, Inc.
  • Boston Scientific Corporation

第5章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's new report, "Japan Gynecological Devices Market Outlook to 2023", provides key market data on the Japan Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Female Sterilization Devices, Endometrial Ablation Devices and Uterine Fibroid Embolization Agents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Gynecological Devices market segments - Female Sterilization Devices, Endometrial Ablation Device and Uterine Fibroid Embolization Agents.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the Japan Gynecological Devices market.
  • Key players covered include Merit Medical Systems, Inc., Alfresa Pharma Corp, Bayer AG and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Introduction 4

  • 2.1 What Is This Report About? 4
  • 2.2 Gynecological Devices Market Segmentation 4
  • 2.3 Definitions of Markets Covered in the Report 5

3 Gynecological Devices Market, Japan 6

  • 3.1 Gynecological Devices Market, Japan, Revenue ($m), 2009-2016 6
  • 3.2 Gynecological Devices Market, Japan, Revenue ($m), 2016-2023 8
    • 3.2.1 Endometrial Ablation Devices Market, Japan, Revenue ($m), by Segment, 2009-2016 10
    • 3.2.2 Female Sterilization Devices Market, Japan, Revenue ($m), by Segment, 2009-2016 11
    • 3.2.3 Uterine Fibroid Embolization Agents Market, Japan, Revenue ($m), by Segment, 2009-2016 12
    • 3.2.4 Endometrial Ablation Devices Market, Japan, Revenue ($m), by Segment, 2016-2023 13
    • 3.2.5 Female Sterilization Devices Market, Japan, Revenue ($m), by Segment, 2016-2023 14
    • 3.2.6 Uterine Fibroid Embolization Agents Market, Japan, Revenue ($m), by Segment, 2016-2023 15
  • 3.3 Gynecological Devices Market, Japan, Volume (Units), 2009-2016 17
  • 3.4 Gynecological Devices Market, Japan, Volume (Units), 2016-2023 19
    • 3.4.1 Endometrial Ablation Devices Market, Japan, Volume (Units), by Segment, 2009-2016 21
    • 3.4.2 Female Sterilization Devices Market, Japan, Volume (Units), by Segment, 2009-2016 22
    • 3.4.3 Uterine Fibroid Embolization Agents Market, Japan, Volume (Units), by Segment, 2009-2016 24
    • 3.4.4 Endometrial Ablation Devices Market, Japan, Volume (Units), by Segment, 2016-2023 25
    • 3.4.5 Female Sterilization Devices Market, Japan, Volume (Units), by Segment, 2016-2023 26
    • 3.4.6 Uterine Fibroid Embolization Agents Market, Japan, Volume (Units), by Segment, 2016-2023 28
  • 3.5 Gynecological Devices Market, Japan, Average Price ($), 2009-2023 29
  • 3.6 Gynecological Devices Market, Japan, Distribution Share by Revenue ($m), 2016 31
  • 3.7 Gynecological Devices Market, Japan, Company Share by Revenue ($m), 2016 32

4 Overview of Key Companies in Japan, Gynecological Devices Market 33

  • 4.1 Merit Medical Systems, Inc. 33
    • 4.1.1 Company Overview 33
  • 4.2 Alfresa Pharma Corp 33
    • 4.2.1 Company Overview 33
  • 4.3 Bayer AG 33
    • 4.3.1 Company Overview 33
  • 4.4 Utah Medical Products, Inc. 34
    • 4.4.1 Company Overview 34

5 Gynecological Devices Market Pipeline Products 35

6 Appendix 36

  • 6.1 Research Methodology 37
    • 6.1.1 Coverage 37
    • 6.1.2 Secondary Research 37
    • 6.1.3 Primary Research 38
    • 6.1.4 Market Modeling and Forecasting 39
    • 6.1.5 Company Share Analysis 40
    • 6.1.6 Distribution Share Analysis 41
    • 6.1.7 Benchmarking 41
  • 6.2 GlobalData Consulting 41
  • 6.3 Contact Us 42
  • 6.4 Disclaimer 42

List of Tables

1.1 List of Tables

  • Table 1: Gynecological Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 7
  • Table 2: Gynecological Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 9
  • Table 3: Endometrial Ablation Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 10
  • Table 4: Female Sterilization Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 11
  • Table 5: Uterine Fibroid Embolization Agents Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 12
  • Table 6: Endometrial Ablation Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 13
  • Table 7: Female Sterilization Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 14
  • Table 8: Uterine Fibroid Embolization Agents Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 16
  • Table 9: Gynecological Devices Market, Japan, Volume (Units), Historic, 2009-2016 18
  • Table 10: Gynecological Devices Market, Japan, Volume (Units), Forecast, 2016-2023 20
  • Table 11: Endometrial Ablation Devices Market, Japan, Volume (Units), Historic, 2009-2016 21
  • Table 12: Female Sterilization Devices Market, Japan, Volume (Units), Historic, 2009-2016 23
  • Table 13: Uterine Fibroid Embolization Agents Market, Japan, Volume (Units), Historic, 2009-2016 24
  • Table 14: Endometrial Ablation Devices Market, Japan, Volume (Units), Forecast, 2016-2023 25
  • Table 15: Female Sterilization Devices Market, Japan, Volume (Units), Forecast, 2016-2023 27
  • Table 16: Uterine Fibroid Embolization Agents Market, Japan, Volume (Units), Forecast, 2016-2023 28
  • Table 17: Gynecological Devices Market, Japan, Average Price ($) Historic, 2009-2023 29
  • Table 18: Gynecological Devices Market, Japan, Average Price ($), Forecast, 2016-2023 30
  • Table 19: Gynecological Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2016 31
  • Table 20: Gynecological Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 32
  • Table 21: Gynecological Devices Market Pipeline Products 35
  • Table 22: Total Number of Primary Research Participants, General Surgery Market, by Country 39

List of Figures

1.2 List of Figures

  • Figure 1: Gynecological Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 6
  • Figure 2: Gynecological Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 8
  • Figure 3: Endometrial Ablation Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 10
  • Figure 4: Female Sterilization Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 11
  • Figure 5: Uterine Fibroid Embolization Agents Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 12
  • Figure 6: Endometrial Ablation Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 13
  • Figure 7: Female Sterilization Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 14
  • Figure 8: Uterine Fibroid Embolization Agents Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 15
  • Figure 9: Gynecological Devices Market, Japan, Volume (Units), Historic, 2009-2016 17
  • Figure 10: Gynecological Devices Market, Japan, Volume (Units), Forecast, 2016-2023 19
  • Figure 11: Endometrial Ablation Devices Market, Japan, Volume (Units), Historic, 2009-2016 21
  • Figure 12: Female Sterilization Devices Market, Japan, Volume (Units), Historic, 2009-2016 22
  • Figure 13: Uterine Fibroid Embolization Agents Market, Japan, Volume (Units), Historic, 2009-2016 24
  • Figure 14: Endometrial Ablation Devices Market, Japan, Volume (Units), Forecast, 2016-2023 25
  • Figure 15: Female Sterilization Devices Market, Japan, Volume (Units), Forecast, 2016-2023 26
  • Figure 16: Uterine Fibroid Embolization Agents Market, Japan, Volume (Units), Forecast, 2016-2023 28
  • Figure 17: Gynecological Devices Market, Japan, Company Share (%) 2016 32
Back to Top